ViiV Healthcare (GSK) Statistics Director

10480 ViiV Healthcare Company
Stevenage
10 months ago
Create job alert

ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care.

We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic. We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference.

While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities.

TheStatistics Directorwill provide leadership and support relating to the Quantitative Data Sciences (Statistics) areas of statistics, statistical programming, and clinical data management for ViiV Healthcare (VH) for one or more programs.

This role is eligible for domestic relocation within the respective countries, US or UK.

Apply expertise relating to Statistics to specific products throughout their VH life cycle. Support Statistics product and project strategy in alignment with VH strategy. Proactively influence external opinion leaders and regulatory authorities related to Statistics methodology. Ensure Statistics product and project strategies are robust and effectively defended in interactions with senior internal groups and with regulatory authorities, external expert groups, lawyers and other companies.  Responsible for the statistical validity of data dissemination related to supported programs. Prepare and deliver Headline Reports and related disseminations of results from VH clinical studies Lead and deliver asset level pooled/meta-analyses of internal and external clinical trials and observational data. Member of and key contributor to various VH teams (Medicine Development, Clinical Matrix, Global Collaborative Trials, Data Dissemination, etc…). Effective partnership with Medicines Development Leaders, Clinical Investigations Leaders, and others. Direct collaboration with and oversight of 3rd parties in fulfillment of responsibilities supporting VH programs, including capacity management and trouble-shooting problems related to project delivery Understand, assess and communicate Statistics aspects of project strategies & deliverables to key stakeholders.  Provides statistics training and education to various areas of the company. Ensure appropriate interpretation and use of internal and external interventional and observational data. Support VH Head of Statistics and others in relationship to Statistics governance and procedural documentation, functional capability development, compliance, best practices, training and recruitment. Global (indirect) leadership and oversight of 3rd party suppliers of project level statistical and programming resource (eg GSK and Pfizer) to VH. Accountable for statistical (e.g., randomization/blinding/unblinding, protocol development, analysis planning, ADaM and TLF) deliverables and key milestones for supported projects. Consults with Programming and Data Management colleagues regarding deliverables relating to programming and data management activities, including but not limited to: database set up, data standards (CDISC), analysis database conversions (eg, ADaM), data repository, and data re-use. Statistical approval for regulatory correspondence, submissions, protocols, reports, and other deliverables. Statistical quality of relevant VH Medical Comments and related materials.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

Masters in Statistics or Biostatistics & 10 plus years of experience OR PhD & 5 plus years in statistics for drug development, including clinical development and/or post-marketing 5 plus years of leadership experience in a matrix environment, including influence and negotiation with the business Experience leading Statistics aspects from study design to final analysis and dissemination Direct experience in developing and delivering presentations & publications

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

Experience in advanced innovative statistical methodology Effective verbal and written communication skills

Excellent interpersonal skills including relationship building and maintenance

Please visit to learn more about the comprehensive benefits program ViiV offers US employees. All ViiV employees receive the same benefits options and plans as GSK employee.

Why Us?

At ViiV Healthcare, we will not rest until we leave no person living with HIV behind. Until the 39 million people living with HIV is down to zero, we will continue searching for new ways to limit the impact of HIV. 

We are the only pharmaceutical company solely focused on combating, preventing, and ultimately eradicating HIV and AIDS. At ViiV Healthcare, we do things differently. Born out of a partnership between and in 2009, with joining in 2012, we are determined to help end the HIV epidemic. We are guided by our mission to leave no person living with HIV behind and it is this mission that unites our employees located across the globe. We combine expertise in research, manufacturing, policy and more to push the boundaries of what people think is possible in HIV treatment and care. As a result of our connection with GSK, we are able to draw on their proud history and resources. This means that you would receive all the employee benefits offered by GSK.

Living our mission of leaving no person living with HIV behind means keeping inclusion and diversity at the heart of everything we do - from our breakthrough innovation, to our diverse portfolio of medicines as well as the work we do to partner with HIV communities. Having a diverse team and a truly inclusive culture where we’re all able to be ourselves and feel like we belong will make us an even stronger team, better able to perform as a business and deliver on our mission to leave no person living with HIV behind.

ViiV is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

Important notice to Employment businesses/ Agencies

ViiV does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact ViiV's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to ViiV. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and ViiV. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of ViiV. ViiV shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Contract vs Permanent Machine Learning Jobs: Which Pays Better in 2025?

Machine learning (ML) has swiftly become one of the most transformative forces in the UK technology landscape. From conversational AI and autonomous vehicles to fraud detection and personalised recommendations, ML algorithms are reshaping how organisations operate and how consumers experience products and services. In response, job opportunities in machine learning—including roles in data science, MLOps, natural language processing (NLP), computer vision, and more—have risen dramatically. Yet, as the demand for ML expertise booms, professionals face a pivotal choice about how they want to work. Some choose day‑rate contracting, leveraging short-term projects for potentially higher immediate pay. Others embrace fixed-term contract (FTC) roles for mid-range stability, or permanent positions for comprehensive benefits and a well-defined career path. In this article, we will explore these different employment models, highlighting the pros and cons of each, offering sample take‑home pay scenarios, and providing insights into which path might pay better in 2025. Whether you’re a new graduate with a machine learning degree or an experienced practitioner pivoting into an ML-heavy role, understanding these options is key to making informed career decisions.

Machine‑Learning Jobs for Non‑Technical Professionals: Where Do You Fit In?

The Model Needs More Than Math When ChatGPT went viral and London start‑ups raised seed rounds around “foundation models,” many professionals asked, “Do I need to learn PyTorch to work in machine learning?” The answer is no. According to the Turing Institute’s UK ML Industry Survey 2024, 39 % of advertised ML roles focus on strategy, compliance, product or operations rather than writing code. As models move from proof‑of‑concept to production, demand surges for specialists who translate algorithms into business value, manage risk and drive adoption. This guide reveals the fastest‑growing non‑coding ML roles, the transferable skills you may already have, real transition stories and a 90‑day action plan—no gradient descent necessary.

Quantexa Machine‑Learning Jobs in 2025: Your Complete UK Guide to Joining the Decision‑Intelligence Revolution

Money‑laundering rings, sanctioned entities, synthetic identities—complex risks hide in plain sight inside data. Quantexa, a London‑born scale‑up now valued at US $2.2 bn (Series F, August 2024), solves that problem with contextual decision‑intelligence (DI): graph analytics, entity resolution and machine learning stitched into a single platform. Banks, insurers, telecoms and governments from HSBC to HMRC use Quantexa to spot fraud, combat financial crime and optimise customer engagement. With the launch of Quantexa AI Studio in February 2025—bringing generative AI co‑pilots and large‑scale Graph Neural Networks (GNNs) to the platform—the company is hiring at record pace. The Quantexa careers portal lists 450+ open roles worldwide, over 220 in the UK across data science, software engineering, ML Ops and client delivery. Whether you are a graduate data scientist fluent in Python, a Scala veteran who loves Spark or a solutions architect who can turn messy data into knowledge graphs, this guide explains how to land a Quantexa machine‑learning job in 2025.